Regulation of T Cell Differentiation and Alloimmunity by the Cyclin-Dependent Kinase Inhibitor p18ink4c

por Rowell, Emily A., Wang, Liqing, Chunder, Neelanjana, Hancock, Wayne W., Wells, Andrew D.
Publicado 2014

RETRACTED ARTICLE: A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function

por To, Jeremy, Quackenbush, Doug, Rowell, Emily, Li, Lilin, Reed, Connor, Lo, Frederick, Horman, Shane R.
Publicado 2021

Retraction Note: A biomimetic assay platform for the interrogation of antigen-dependent anti-tumor T-cell function

por To, Jeremy, Quackenbush, Doug, Rowell, Emily, Li, Lilin, Reed, Connor, Lo, Frederick, Horman, Shane R.
Publicado 2021

INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses

por Sulzmaier, Florian J, Kern, Nadja, Ahn, Sae Jeong, Polovina, Anya, Ho, Jason, Hussain, Abrahim, Cyprus, Garrett, Macedo, Chelsie, Pandit, Rajay, Crago, William, Rowell, Emily, Timmer, John C, Eckelman, Brendan P
Publicado 2023

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

por Subbiah, Vivek, Chawla, Sant P., Conley, Anthony P., Wilky, Breelyn A., Tolcher, Anthony, Lakhani, Nehal J., Berz, David, Andrianov, Vasily, Crago, William, Holcomb, Monica, Hussain, Abrahim, Veldstra, Carson, Kalabus, James, O’Neill, Brianne, Senne, Lane, Rowell, Emily, Heidt, Analeah B., Willis, Katelyn M., Eckelman, Brendan P.
Publicado 2023